Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Chief Suggests Looking Outside Pharma For Tips On Quality Systems

Executive Summary

FDA Commissioner Andrew von Eschenbach asked a group of medical products industry representatives July 9 to "think outside the box" to identify role models or lessons learned from other industries that could help address the challenges of drug import safety in a global marketplace

You may also be interested in...



Import Safety Pilot Casts Global Inspection Net For Drug Manufacturers

HHS Secretary Leavitt announces plan to move regulators away from reliance on border inspections.

Sen. Kennedy’s Foreign Inspection Bill Gives FDA More Flexibility Than House

House and Senate Democrats are taking similar approaches in regard to invigorating FDA's ability to oversee foreign manufacturing facilities. But some fundamental differences and Republican concerns suggest that the issue will likely not be resolved until at least the next Congress

Heparin to star at House hearings

Events leading up to the distribution of contaminated heparin will be the focus of hearings tentatively scheduled for April 15 by House Energy & Commerce Oversight and Investigations Subcommittee. A week later, FDA Commissioner Andrew von Eschenbach will be asked to provide scenarios for revamping the agency's foreign drug plant inspection program. Seeking an end to the "unsafe" drug import saga, full committee chairman John Dingell, D-Mich., plans action this year on legislation that would assess annual drug import fees of $300 million to pay for inspection of drug imports (1"The Pink Sheet," Aug. 13, 2007, p. 21)

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel